- Home
- OSBC vs ORIC Comparison
OSBC vs ORIC Comparison
Compare OSBC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSBC
- ORIC
- Stock Information
- Founded
- OSBC 1981
- ORIC 2014
- Country
- OSBC United States
- ORIC United States
- Employees
- OSBC N/A
- ORIC N/A
- Industry
- OSBC Major Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- OSBC Finance
- ORIC Health Care
- Exchange
- OSBC Nasdaq
- ORIC Nasdaq
- Market Cap
- OSBC 722.5M
- ORIC 750.6M
- IPO Year
- OSBC N/A
- ORIC 2020
- Fundamental
- Price
- OSBC $18.46
- ORIC $8.50
- Analyst Decision
- OSBC Buy
- ORIC Strong Buy
- Analyst Count
- OSBC 4
- ORIC 9
- Target Price
- OSBC $18.75
- ORIC $18.75
- AVG Volume (30 Days)
- OSBC 319.4K
- ORIC 499.8K
- Earning Date
- OSBC 10-16-2024
- ORIC 11-12-2024
- Dividend Yield
- OSBC 1.30%
- ORIC N/A
- EPS Growth
- OSBC N/A
- ORIC N/A
- EPS
- OSBC 1.85
- ORIC N/A
- Revenue
- OSBC $264,069,000.00
- ORIC N/A
- Revenue This Year
- OSBC N/A
- ORIC N/A
- Revenue Next Year
- OSBC N/A
- ORIC N/A
- P/E Ratio
- OSBC $9.98
- ORIC N/A
- Revenue Growth
- OSBC N/A
- ORIC N/A
- 52 Week Low
- OSBC $13.00
- ORIC $6.33
- 52 Week High
- OSBC $18.86
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- OSBC 66.09
- ORIC 37.50
- Support Level
- OSBC $16.01
- ORIC $10.06
- Resistance Level
- OSBC $18.86
- ORIC $11.11
- Average True Range (ATR)
- OSBC 0.53
- ORIC 0.81
- MACD
- OSBC 0.15
- ORIC -0.05
- Stochastic Oscillator
- OSBC 85.96
- ORIC 13.00
About OSBC Old Second Bancorp Inc.
Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The company's revenue consists of interest, commission, payments, and other income.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.